- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT04828655
Analysis of Bioparametric Measures for Correlating Daily Habits and Reducing Blood Pressure
Análisis de Medidas bioparamétricas Para Correlacionar Los hábitos Diarios y Reducir la tensión Arterial
Aperçu de l'étude
Statut
Les conditions
Description détaillée
In the Valencian Community, 93% of deaths appear to be related to (non-communicable) diseases such as: obesity, hypertension and diabetes. In 2013, cardiovascular diseases were the leading cause of death in women (34.4%) and the second in men (28.0%). There is a forecast that overweight and obesity will reach levels of 89% and 85% in men and women, respectively, by 2030. This will result in an increase in the obesity-related prevalence of coronary heart disease by 97%. The promotion of research on arterial hypertension and how it could be reduced is one of the basic pillars in decreasing the prevalence and incidence in the Spanish population. Research should anticipate and develop treatments and vaccines that prevent new scenarios of widespread infection.
Therefore, the main objective is to study the effects of the use of a mobile application plus recommendations based on a Mediterranean diet on the intake of micronutrients from natural sources (not drugs) on health indicators, cardiovascular parameters (blood pressure...), physical condition and body composition in the adult Spanish population.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Alicante, Espagne, 03690
- Alejandro Martínez Rodríguez
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Over 40 years old
- Healthy.
- Blood pressure levels slightly elevated but less than 140 mm Hg and/or diastolic pressure less than 90 mm Hg.
- Smartphone access
Exclusion Criteria:
- Subjects with diseases.
- Consumption of drugs and/or supplements.
- Subjects with food intolerances/allergies.
- Subjects with muscle or joint injury.
- Subjects with impossibility to follow up the intervention.
- Refusal of informed consent
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation croisée
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Aucune intervention: CONTROL GROUP
Recommendations on healthy eating habits based on the Mediterranean diet and moderate physical activity.
Specific micronutrient intake focused on improving cardiovascular parameters and body composition.
|
|
Expérimental: EXPERIMENTAL GROUP
Recommendations on healthy eating habits based on the Mediterranean diet and moderate physical activity through an application based on machine learning.
Intake of specific micronutrients focused on improving cardiovascular parameters and body composition.
|
Specific diet program and moderate physical activity, all guided and mediated by a mobile application.
As well as the recording and monitoring of periodic evaluations of health indicators.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Cardiovascular variables; heart rate.
Délai: 9 months
|
Heart rate measurement done with an activity wristband.
|
9 months
|
Cardiovascular variables; blood pressure.
Délai: 9 months
|
Measurement of blood pressure (systolic and diastolic) with a digital tensiometer.
|
9 months
|
Physical condition; time.
Délai: 9 months
|
The evaluation of the physical condition will be carried out by means of the mile test, in which the subjects have to cover this distance walking, and in the shortest possible time.
|
9 months
|
Body Composition - Bioimpedance
Délai: 9 months
|
Assessment of body composition using the TANITA (Tokyo, Japan) validated bioimpedance scale to obtain the results of fat mass, fat-free mass and visceral mass.
|
9 months
|
Weight
Délai: 9 months
|
The weight of the subjects will be obtained using the TANITA (Tokyo, Japan).
From the body mass and height data, the BMI (kg/m2) will be obtained.
|
9 months
|
Height
Délai: 9 months
|
The height of the subjects will be measured with the SECA 123 stadiometer (Hamburg, Germany).
From the body mass and height data, the BMI (kg/m2) will be obtained.
|
9 months
|
Body Composition - Skinfolds
Délai: 9 months
|
The kinanthropometric assessment will be carried out using the methodology proposed for the restricted profile by the International Society for the Development of Kineanthropometry (ISAK).
The material used to measure skinfolds will be a plicometer.
|
9 months
|
Body Composition - Perimeters
Délai: 9 months
|
The kinanthropometric assessment will be carried out using the methodology proposed for the restricted profile by the International Society for the Development of Kineanthropometry (ISAK).
The material used to measure perimeters will be a tape.
|
9 months
|
Body Composition - Diameters
Délai: 9 months
|
The kinanthropometric assessment will be carried out using the methodology proposed for the restricted profile by the International Society for the Development of Kineanthropometry (ISAK).
The material used to measure diameters will be a pachymeter.
|
9 months
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Alejandro Martínez Rodríguez, Alicante University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- UA-2020-04-16
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .